NCT07282093
- Conditions
- Olverembatinib, Pharmacokinetic
- Locations
-
- The First Affiliated Hospital of Suzhou Medical University Suzhou, Jiangsu, China
Clinical trial condition
Olverembatinib
Explore clinical trials studying Olverembatinib. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Olverembatinib trial results
NCT07178912
- Conditions
- Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States